0
0
8/15/22 at 12:03pm
Organization
PMLiVE
34 words
0
Comments
RSV is the leading global cause of infant hospitalisation and affects 90% of children under the age of two
You are the first to view
https://www.pmlive.com/pharma_news/sanofi_and_nihr_enrol_first_patient_in_immunisation_study_for_rsv_in_infants_1453345
Create an account
or login to join the discussion